GGrantIndex
Sort

82,697 grants matching vaccine development

University of Washington Arboviral Research Network (UWARN)

$1,691,975
Wesley C Van Voorhis · University Of Washington · U01 · FY2022 · AI

DEVELOPMENT OF CANDIDA-STAPHYLOCOCCUS VACCINE

$1,691,478
Novadigm Therapeutics, Inc. · · FY2009 · Department of the Army

Preclinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine

$1,691,372
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2010 · AI

Pathogenesis of Acute CNS infection and injury

$1,691,119
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS

IMPACTA PERU CLINICAL TRIALS UNIT

$1,691,063
Javier R Lama · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2017 · AI

NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT

$1,690,690
Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2017 · AI

improving outcomes after stem cell transplantation

$1,690,370
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL

DEVELOPMENT OF TUBERCULOSIS VACCINE FORMULATIONS

$1,690,338
Chris Fox · Access To Advanced Health Institute · N01 · FY2016 · AI

Noroviruses and Epidemic Gastroenteritis

$1,690,316
Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Evolution & Maintenance of Memory CD8 T Cells

$1,690,085
Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI

Early life respiratory viral infections shape immune development trajectories

$1,689,999
Octavio Ramilo · Research Inst Nationwide Children'S Hosp · U19 · FY2022 · AI

SPORE University of Texas M. D. Anderson Cancer Center-Leukemia

$1,689,836
Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA

SPORE University of Texas M. D. Anderson Cancer Center-Leukemia

$1,689,836
Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA

Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling

$1,689,695
Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2014 · HG

Mechanisms of Peripheral Induction of T-cell Tolerance

$1,689,694
Matthew F Mescher · University Of Minnesota · P01 · FY2014 · AI

EPITHELIAL OVARIAN CANCER PROGRAM PROJECT

$1,689,458
Sloan-Kettering Institute For Cancer Res · P01 · FY2000 · CA

Mechanisms of Peripheral Induction of T-cell Tolerance

$1,689,418
Kristin A. Hogquist · University Of Minnesota · P01 · FY2017 · AI

Population-based Approach to Malaria Research and Control

$1,689,381
Donald J. Krogstad · Tulane University Of Louisiana · U19 · FY2016 · AI

Evolution & Maintenance of Memory CD8 T Cells

$1,689,155
Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2006 · AI

Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75

$1,688,993
Sean X Leng · Johns Hopkins University · U01 · FY2023 · AI

Cellular and Molecular Physiology of Bloodstream Malaria Parasites

$1,688,469
Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA

$1,688,420
John Wayne Cancer Institute · R01 · FY2000 · CA

Early life respiratory viral infections shape immune development trajectories

$1,688,409
Octavio Ramilo · St. Jude Children'S Research Hospital · U19 · FY2024 · AI

DNA/MWA Immunogens, Cross-clade Immune Responses

$1,688,283
Emory University · P01 · FY2005 · AI

Molecular Studies on HIV Envelope for Vaccine Design

$1,688,015
Dennis R. Burton · Maxygen, Inc. · P01 · FY2009 · AI